Stay updated on ONC201 + Nivolumab in MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.

Latest updates to the ONC201 + Nivolumab in MSS mCRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page no longer displays the 403 error or the NIH transition announcement, and the “Home” breadcrumb and study-navigation labels are absent. The site header and footer remain visible.SummaryDifference2%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.8.0 instead of v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH announcement banner was added, describing a terminology change from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check63 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study content, replacing the previously visible details with a standard error page and blocking access to study information and related resources.SummaryDifference19%

Stay in the know with updates to ONC201 + Nivolumab in MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.